These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 9060904

  • 1. Clinical features of hypertrophic cardiomyopathy caused by mutation of a "hot spot" in the alpha-tropomyosin gene.
    Coviello DA, Maron BJ, Spirito P, Watkins H, Vosberg HP, Thierfelder L, Schoen FJ, Seidman JG, Seidman CE.
    J Am Coll Cardiol; 1997 Mar 01; 29(3):635-40. PubMed ID: 9060904
    [Abstract] [Full Text] [Related]

  • 2. Mutations in the genes for cardiac troponin T and alpha-tropomyosin in hypertrophic cardiomyopathy.
    Watkins H, McKenna WJ, Thierfelder L, Suk HJ, Anan R, O'Donoghue A, Spirito P, Matsumori A, Moravec CS, Seidman JG.
    N Engl J Med; 1995 Apr 20; 332(16):1058-64. PubMed ID: 7898523
    [Abstract] [Full Text] [Related]

  • 3. A de novo mutation in alpha-tropomyosin that causes hypertrophic cardiomyopathy.
    Watkins H, Anan R, Coviello DA, Spirito P, Seidman JG, Seidman CE.
    Circulation; 1995 May 01; 91(9):2302-5. PubMed ID: 7729014
    [Abstract] [Full Text] [Related]

  • 4. Alpha-tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: a disease of the sarcomere.
    Thierfelder L, Watkins H, MacRae C, Lamas R, McKenna W, Vosberg HP, Seidman JG, Seidman CE.
    Cell; 1994 Jun 03; 77(5):701-12. PubMed ID: 8205619
    [Abstract] [Full Text] [Related]

  • 5. Inducibility of life-threatening ventricular arrhythmias is related to maximum left ventricular thickness and clinical markers of sudden cardiac death in patients with hypertrophic cardiomyopathy attributable to the Asp175Asn mutation in the alpha-tropomyosin gene.
    Hedman A, Hartikainen J, Vanninen E, Laitinen T, Jääskeläinen P, Laakso M, Peuhkurinen K, Kuusisto J.
    J Mol Cell Cardiol; 2004 Jan 03; 36(1):91-9. PubMed ID: 14734051
    [Abstract] [Full Text] [Related]

  • 6. Hypertrophic cardiomyopathy caused by a novel alpha-tropomyosin mutation (V95A) is associated with mild cardiac phenotype, abnormal calcium binding to troponin, abnormal myosin cycling, and poor prognosis.
    Karibe A, Tobacman LS, Strand J, Butters C, Back N, Bachinski LL, Arai AE, Ortiz A, Roberts R, Homsher E, Fananapazir L.
    Circulation; 2001 Jan 02; 103(1):65-71. PubMed ID: 11136687
    [Abstract] [Full Text] [Related]

  • 7. Cine MR imaging of myocardial contractile impairment in patients with hypertrophic cardiomyopathy attributable to Asp175Asn mutation in the alpha-tropomyosin gene.
    Sipola P, Lauerma K, Jääskeläinen P, Laakso M, Peuhkurinen K, Manninen H, Aronen HJ, Kuusisto J.
    Radiology; 2005 Sep 02; 236(3):815-24. PubMed ID: 16014439
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A mutant tropomyosin that causes hypertrophic cardiomyopathy is expressed in vivo and associated with an increased calcium sensitivity.
    Bottinelli R, Coviello DA, Redwood CS, Pellegrino MA, Maron BJ, Spirito P, Watkins H, Reggiani C.
    Circ Res; 2005 Sep 02; 82(1):106-15. PubMed ID: 9440709
    [Abstract] [Full Text] [Related]

  • 10. Diastolic dysfunction without left ventricular hypertrophy is an early finding in children with hypertrophic cardiomyopathy-causing mutations in the beta-myosin heavy chain, alpha-tropomyosin, and myosin-binding protein C genes.
    Poutanen T, Tikanoja T, Jääskeläinen P, Jokinen E, Silvast A, Laakso M, Kuusisto J.
    Am Heart J; 2006 Mar 02; 151(3):725.e1-725.e9. PubMed ID: 16504640
    [Abstract] [Full Text] [Related]

  • 11. Sarcomere protein gene mutations in hypertrophic cardiomyopathy of the elderly.
    Niimura H, Patton KK, McKenna WJ, Soults J, Maron BJ, Seidman JG, Seidman CE.
    Circulation; 2002 Jan 29; 105(4):446-51. PubMed ID: 11815426
    [Abstract] [Full Text] [Related]

  • 12. Clinical implications of hypertrophic cardiomyopathy associated with mutations in the alpha-tropomyosin gene.
    Yamauchi-Takihara K, Nakajima-Taniguchi C, Matsui H, Fujio Y, Kunisada K, Nagata S, Kishimoto T.
    Heart; 1996 Jul 29; 76(1):63-5. PubMed ID: 8774330
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Left ventricular hypertrophy and morphology in familial hypertrophic cardiomyopathy associated with mutations of the beta-myosin heavy chain gene.
    Solomon SD, Wolff S, Watkins H, Ridker PM, Come P, McKenna WJ, Seidman CE, Lee RT.
    J Am Coll Cardiol; 1993 Aug 29; 22(2):498-505. PubMed ID: 8335820
    [Abstract] [Full Text] [Related]

  • 16. Codon 102 of the cardiac troponin T gene is a putative hot spot for mutations in familial hypertrophic cardiomyopathy.
    Forissier JF, Carrier L, Farza H, Bonne G, Bercovici J, Richard P, Hainque B, Townsend PJ, Yacoub MH, Fauré S, Dubourg O, Millaire A, Hagège AA, Desnos M, Komajda M, Schwartz K.
    Circulation; 1996 Dec 15; 94(12):3069-73. PubMed ID: 8989109
    [Abstract] [Full Text] [Related]

  • 17. Prevalence and severity of "benign" mutations in the beta-myosin heavy chain, cardiac troponin T, and alpha-tropomyosin genes in hypertrophic cardiomyopathy.
    Van Driest SL, Ackerman MJ, Ommen SR, Shakur R, Will ML, Nishimura RA, Tajik AJ, Gersh BJ.
    Circulation; 2002 Dec 10; 106(24):3085-90. PubMed ID: 12473556
    [Abstract] [Full Text] [Related]

  • 18. Molecular genetics of hypertrophic cardiomyopathy.
    Towbin JA.
    Curr Cardiol Rep; 2000 Mar 10; 2(2):134-40. PubMed ID: 10980884
    [Abstract] [Full Text] [Related]

  • 19. Cardiac myosin binding protein-C gene splice acceptor site mutation is associated with familial hypertrophic cardiomyopathy.
    Bonne G, Carrier L, Bercovici J, Cruaud C, Richard P, Hainque B, Gautel M, Labeit S, James M, Beckmann J, Weissenbach J, Vosberg HP, Fiszman M, Komajda M, Schwartz K.
    Nat Genet; 1995 Dec 10; 11(4):438-40. PubMed ID: 7493026
    [Abstract] [Full Text] [Related]

  • 20. First-pass MR imaging in the assessment of perfusion impairment in patients with hypertrophic cardiomyopathy and the Asp175Asn mutation of the alpha-tropomyosin gene.
    Sipola P, Lauerma K, Husso-Saastamoinen M, Kuikka JT, Vanninen E, Laitinen T, Manninen H, Niemi P, Peuhkurinen K, Jääskeläinen P, Laakso M, Kuusisto J, Aronen HJ.
    Radiology; 2003 Jan 10; 226(1):129-37. PubMed ID: 12511681
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.